Aveanna Healthcare Holdings Inc [AVAH] stock is trading at $7.2, up 0.70%. An important factor to consider is whether the stock is rising or falling in short-term value. The AVAH shares have gain 23.92% over the last week, with a monthly amount glided 80.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] stock has seen the most recent analyst activity on July 21, 2025, when Jefferies upgraded its rating to a Buy but kept the price target unchanged to $6 for it. Previously, Barclays started tracking the stock with Equal Weight rating on July 02, 2025, and set its price target to $5.50. On December 13, 2023, downgrade downgraded it’s rating to Underweight. UBS started tracking the stock assigning a Sell rating and suggested a price target of $1.50 on November 30, 2023. Raymond James downgraded its rating to a Mkt Perform. Credit Suisse downgraded its rating to Underperform for this stock on January 27, 2023, and downed its price target to $1. In a note dated November 21, 2022, RBC Capital Mkts downgraded an Sector Perform rating on this stock and revised its target price from $7 to $3.
Aveanna Healthcare Holdings Inc [AVAH] stock has fluctuated between $3.67 and $7.61 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] shares were valued at $7.2 at the most recent close of the market. An investor can expect a potential return of 25.0% based on the average AVAH price forecast.
Analyzing the AVAH fundamentals
Aveanna Healthcare Holdings Inc [NASDAQ:AVAH] reported sales of 2.18B for the trailing twelve months, which represents a growth of 16.75%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.19 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -124.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.03 points at the first support level, and at 6.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.37, and for the 2nd resistance point, it is at 7.55.
Ratios To Look Out For
For context, Aveanna Healthcare Holdings Inc’s Current Ratio is 1.09. On the other hand, the Quick Ratio is 1.09, and the Cash Ratio is 0.24. Considering the valuation of this stock, the price to sales ratio is 0.69 and price to earnings (TTM) ratio is 95.74.
Transactions by insiders
Recent insider trading involved Cunningham Patrick A., Chief Compliance Officer, that happened on Jun 13 ’25 when 18500.0 shares were sold. 10% Owner, J.H. Whitney Equity Partners V completed a deal on Jun 10 ’25 to sell 0.75 million shares. Meanwhile, 10% Owner VIGANO PAUL R sold 0.75 million shares on Jun 10 ’25.
